Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Liver Imaging

Composite liver tumors: A radiologic-pathologic correlation

Megha Nayyar, David K. Imagawa, Temel Tirkes, Aram N. Demirjian, Roozbeh Houshyar, Kumar Sandrasegaran, Chaitali S. Nangia, Tara Seery, P Bhargava, Joon II Choi, Chandana Lall

Clin Mol Hepatol. 2014;20(4):406-410. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.406

View: 7694 Download: 59 Web of Science: 3 Crossref: 3

Chemotherapy induced liver abnormalities: an imaging perspective

Ankush Sharma, Roozbeh Houshyar, Priya Bhosale, Joon-Il Choi, Rajesh Gulati, Chandana Lall

Clin Mol Hepatol. 2014;20(3):317-326. Published online September 25, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.317

View: 14841 Download: 302 Web of Science: 59 Crossref: 55

Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib

Joon-Il Choi, David K Imagawa, Priya Bhosale, Puneet Bhargava, Temel Tirkes, Tara E Seery, Chandana Lall

Clin Mol Hepatol. 2014;20(2):218-222. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.218

View: 6398 Download: 78 Web of Science: 11 Crossref: 12

1 |

Viewed By 5169	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5027	MAFLD: How is it different from NAFLD?
Viewed By 4973	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3647	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3603	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search